ArticleBMC infectious diseases2025
Mortality and associated factors among PLHIV admitted in selected hospitals in Ethiopia: A Cross-sectional Study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe human immunodeficiency virus (HIV) is still a significant global public health concern. Mortality among people living with HIV remains high, predominantly in resource-limited settings. Despite significant progress in HIV care and treatment services, there is limited evidence on mortality among people living with HIV in Ethiopia. Therefore, this study aimed to assess the magnitude of mortality and its associated factors among people living with HIV admitted to selected hospitals in Ethiopia.
methodA facility-based retrospective cross-sectional study was conducted among 10,077 PLHIV admitted to thirty-seven selected hospitals in Ethiopia. Data were collected from patient charts and registration books for the follow-up period between January 2016 and December 2023; cleaned and analyzed by STATA version 17. Descriptive, bivariate and multivariable logistic regression analysis were conducted. The association was measured by adjusted odds ratio (AOR) with 95% CI and p-value less than 0.05 was considered statistically significant.
resultsA total of 10,077 PLHIV were included in this study. The mean age (± SD) was 36.9 ± 13.9 years and 60.28% were females. The magnitude of mortality among PLHIV was 13.2% (95% CI:12.5%-13.9%). Being male (AOR = 1.29; 95% CI:1.14-1.45), aged 45-54 years (AOR = 1.23; 95% CI:1.01-1.52), aged 55 years or older (AOR = 1.40; 95% CI: 1.11-1.77), presence of opportunistic infections (OIs) at admission (AOR = 2.25; 95% CI:1.99-2.56), presence of non-communicable diseases (NCDs) and other comorbidities at admission (AOR = 1.59; 95% CI:1.40-1.81), and inactive ART status at admission (AOR = 1.27; 95% CI:1.12-1.45) were predictors of mortality in this study.
conclusionOne in nearly eight admitted PLHIV die during hospitalization which is driven by male gender, older age, the presence of OIs, NCDs and inactive ART status at admission. Strengthening the health system with gender-specific interventions and routine screening for co-morbidities and OIs is essential. Moreover, further studies using prospective design are recommended. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.